Delivery Order SPE2DB22D9239-SPE2DB24FDH64
Award Date 3/29/24
Potential Completion Date 4/19/24
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,345.85 contract is for the supply of Rituxan 500 mg/50 ml vials. This delivery order is issued against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA under the SPE2DB program, which enables the agency to order a broad range of pharmaceutical...
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a firm fixed-price pricing type issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract, valued at $18,415.02, is to provide the pharmaceutical product Rituxan 500 mg/50 ml vial. This award is not set aside and is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $95,618.70 contract is for the delivery of Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $31,919.10 firm fixed-price delivery order is for the supply of 4559395907, specifically RITUXAN 500 MG/50 ML VIAL 50ML. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB program. The $64,785.40 award is for the supply of 500 mg/50 mL vials of the drug Rituxan (rituximab) to support the recurring medical supply needs of military healthcare facilities. The contract does not have any set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,965.88 by the Defense Logistics Agency (DLA) on August 21, 2025. The delivery order covers Rituxan 500 mg/50 ml vials for delivery to Park Ridge, Illinois, with a firm fixed-price contract type and an ultimate completion date of September 12, 2025. This award carries no set-aside designation, allowing the vendor to compete on an open basis...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,931.76 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, and has an ultimate completion date of May 19, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
- This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Rituxan 500 mg/50 ml vials. The award was made by the Defense Logistics Agency (DLA) under their SPE2DB indefinite delivery contract, valued at up to $4,999,999 through 2025. This contract enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The current delivery...
- This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $6,138.34 contract is for the delivery of the pharmaceutical product RITUXAN 500 MG/50 ML VIAL 50ML, with a completion date of October 9, 2024. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing a wide range...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,965.88 by the Defense Logistics Agency on August 7, 2025. The contract calls for the delivery of Rituxan 500 mg/50 ml vials, a biologic medication commonly used in oncology and rheumatology treatments. This delivery order was issued without a set-aside designation, and performance is scheduled for completion by August...